Table 2. Additional procedure-related information.
| Procedure related information | Value |
|---|---|
| Completed procedure, n (%) | 16 (100.0) |
| Procedure time† (min), median [IQR] | 15 [10–20] |
| Time to discharge (min), median [IQR] | 76 [57–83] |
| Structures biopsied‡, n | |
| Tumour | |
| Mediastinal | 3 |
| Intrapulmonary (LLL and RUL) | 3 |
| Mediastinal lymph nodes§ | 11 |
| Structures biopsied pr procedure, median [range] | 1 [1–3] |
| Medications during procedure | |
| Midazolam, n (%) | 15 (93.8) |
| Median dose (range) (mg) | 2.0 (1.1–2.9) |
| Fentanyl, n (%) | 3 (18.8) |
| Median dose (range) (μg) | 25.0 (12.5–25.0) |
| Sufentanil, n (%) | 5 (31.3) |
| Median dose (range) (μg) | 5.0 (2.5–5.0) |
| Other medications during procedure, n (%) | 0 (0.0) |
| Medications after procedure, n (%) | |
| Vaporized short-acting bronchodilators | 1 (6.3) |
| Flumazinil | 2 (12.5) |
†, time from insertion to removal of the endoscope; ‡, number exceeds total number of patients, as one patient had biopsied from both; §, lymph node stations: 4L, 4R, 5, 7 and 8. IQR, interquartile range; LLL, left lower lobe; RUL, right upper lobe.